
The latest hardware version of the ReguCellTouch—albeit without medical certification—has been given a new name. Its technical advantages include:
For the first time, the FrequencyFirst offers a choice between two photon wavelengths. In addition to the well-known blue light used to treat inflammation, a second interchangeable head featuring near-infrared wavelengths can be utilized to address low energy levels and degenerative conditions. On the FrequencyFirst, the intensity levels for both the Jerico output and the photon emitters are adjusted using separate sliders. The therapy programs are identical to those found on the ReguCellTouch.
The innovative FrequencyFirst is available as a fully equipped package for just € 8,000.00 (plus VAT).
Like all ReguCell products, ReguCell FrequencyFirst stands out as a provider of holistic solutions. Its effective therapy concepts are aimed at maintaining health and strengthening tissue. It offers the treatments of the future through frequency-specific cellular stimulation—combining pleasant microcurrents with simultaneous, stimulating micro-shockwaves.
Treatment concepts are available to suit virtually every individual practice specialization. The applications are consistently pleasant and serve to resolve acute issues, even for the most discerning clients. For over 20 years, our microcurrent treatment has been revolutionizing the fields of preventive care and medicine.